Pinus quadrifolia
Overview
Pinus quadrifolia, commonly known as the Parry pinyon, is a species of pine native to the southwestern United States and northern Mexico. It is a member of the pinyon pine group, which is known for its edible seeds, commonly referred to as pine nuts.
Description
Pinus quadrifolia is a small to medium-sized tree, typically reaching heights of 5 to 15 meters. The tree is characterized by its dense, rounded crown and short, stout trunk. The bark is thick and scaly, providing protection against fire and pests.
The leaves, or needles, are arranged in fascicles of four, which is a distinctive feature of this species. The needles are slender, measuring 2 to 4 cm in length, and have a bluish-green color.
Cones and Seeds
The cones of Pinus quadrifolia are small, measuring 4 to 6 cm in length. They are globular and have thick, woody scales. The seeds are large, wingless, and edible, making them an important food source for wildlife and humans alike. The seeds are typically harvested in the fall.
Habitat and Distribution
Pinus quadrifolia is found in arid and semi-arid regions, often growing on rocky slopes and in dry, open woodlands. It is native to the mountains of southern California and northern Baja California. The species thrives in elevations ranging from 1,200 to 2,500 meters.
Ecology
The Parry pinyon plays a crucial role in its ecosystem. It provides habitat and food for various species of birds and mammals. The seeds are particularly important for Clark's nutcracker and pinyon jay, which help in seed dispersal.
Uses
The seeds of Pinus quadrifolia are harvested for consumption and are considered a delicacy. The wood, although not commercially significant, is used locally for fuel and small construction projects.
Conservation
While Pinus quadrifolia is not currently listed as threatened, its habitat is susceptible to threats such as climate change, wildfires, and land development. Conservation efforts focus on protecting its natural habitat and ensuring sustainable harvesting practices.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD